Pfizer initiates Neuropathic Pain Research Awards
Pfizer Canada initiated the Neuropathic Pain Research Awards Program. Pharmaceutical companies working in the field of neuropathic pain realize that the alliance between industry and academia needs to be fostered.
Therefore, they kick off some nice activities. One example is Pfizer, one of the biggest pharmaceutical companies working in the field of neuropathic pain treatments.
Independent neuropathic pain research
Pfizer Canada developed a Neuropathic Pain Research Awards Competition. Which aims to fund and support independent neuropathic pain research in the areas of basic biomedical, clinical and health sciences.
- “This awards program recognizes the severity of neuropathic pain as a disease and the important work of some of Canada’s leading researchers, who are committed to understanding and learning more about neuropathic pain.”
According to Dr. A. John Clark, Medical Director, Calgary Health Region Chronic Pain Center.
- “The work they are doing is of tremendous importance to not only Canadian patients but people around the world who suffer from this disease.”
Neuropathic pain in Canada
We quote from the Pfizer press release:
Neuropathic pain is a disease caused by injury or dysfunction of the nerves, spinal cord or brain. It is estimated that over 2.2 million Canadians suffer from this chronic condition, often in combination with other types of pain. Such as Fibromyalgia, osteoarthritis and migraine headaches.
Sixteen research proposals were reviewed by an independent committee of Canadian medical researchers, chaired by Dr. Clark, Medical Director. Seven proposals were funded based on ranked scores from the independent review committee. The recipients represent a diverse group of healthcare professionals and scientists, committed to furthering research and understanding of neuropathic pain.
Pfizer Canada is strongly committed to advancing research in the pain therapeutic area. The Pfizer Neuropathic Pain Research Awards were created to support independent researchers. Recognize outstanding research with the potential to improve knowledge and treatment of neuropathic pain. As well as the quality of life of Canadians and people around the world.
Pfizer honors complementary medicine and Integrated Medicine
Some years ago, in the Netherlands project ion neuropathic pain organized by Pfizer in a nice place in Maastricht, Qigong and acupuncture for the treatment of pain was presented as a workshop, and the author of this article was asked to present this workshop.
Many of the anesthesiologists and neurologists enjoyed the Qigong and the acupuncture. Within 2 hours we could transfer the basic skills of administrating a pain killing acupuncture needle to many of the attending physicians.
Now Pfizer again showed support for Integrated Medicine approaches in treating neuropathic pain. One of the recipients of the 2008 awards was Dr. Mary E. Lynch Department of Anesthesia and Psychiatry for her work on ‘A Controlled Trial of Qigong for Treatment of Fibromyalgia’. Dr. Lynch coordinates a controlled clinical study to examine the effects of Qigong for treatment of Fibromyalgia.
Prof. dr. J.M. Keppel Hesselink
‘Pfizer initiates Neuropathic Pain Research Awards’
Watch our video’s about Neuropathy.